The RBA cash rate is back at 2011 levels. The economy underneath it looks nothing like 2011. Duration is what investors ...

The investment regime change underway is unlikely to be temporary. Markets are adjusting to a world that is structurally more ...

Julia Weng (Paradice) and Hamish FitzSimons (AllianceBernstein) diagnose ASX healthcare's brutal year and name the stocks set ...

The Macquarie Conference has become one of the must-attend events in every Australian fund manager’s diary. In this podcast ...

Is this genuine reform or just higher taxes? AMP's Shane Oliver breaks down the upcoming Budget’s biggest challenges.

AI didn't kill ASX SaaS stocks – it killed the multiples investors would pay for them. That distinction could make or break ...

The robo-advisor founder made a calculator showing how an indexation approach could hit after-tax returns from gold, property ...

With the prospect of a full-scale war in the Middle East increasing, with bond yields heating up, and with famed short seller ...

Analysis suggests there is merit to Warsh arguing that trimmed mean inflation is better than the traditional core PCE series.

In a world of hype and headlines, systematic investing keeps investors grounded in what the data is really saying.

NextDC’s recent subordinated note issuance highlights a recurring challenge for credit investors: exposure to equity‑like ...

A near 40% drawdown has forced investors to reassess the healthcare sector. Is this a reset, or are deeper cracks starting to ...